Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2024-11-07
Target enrollment:
Participant gender:
Summary
The objective of research is to evaluate the efficacy and safety of treprizumab injection
combined with AP regimen in the treatment of resectable locally advanced head and neck
squamous cell carcinoma.122 patients were randomly divided into two groups: the test group
(treprizumab injection combined with AP protocol) and the control group (TP protocol); The
patients in both groups were treated with three cycles of induction therapy. After the
induction therapy, the patients were evaluated and followed up with surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital